Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Lands' End
LE
$370M
| $772K | ﹤0.01% |
95,974
+8,955
| +10% | +$64.4K |
|
2702
Cyclerion Therapeutics
CYCN
$14.9M
| $767K | ﹤0.01% |
6,488
+1,146
| +21% | +$95.8K |
|
|
AMRS
2703
DELISTED
Amyris Inc.
AMRS
| $766K | ﹤0.01% |
179,244
+37,702
| +27% | +$125K |
|
2704
Altisource Portfolio Solutions
ASPS
$63.6M
| $764K | ﹤0.01% |
6,474
+212
| +3% | +$17.4K |
|
2705
SAP
SAP
$212B
| $764K | ﹤0.01% |
+5,454
| New | +$672K |
|
2706
Rigel Pharmaceuticals
RIGL
$681M
| $763K | ﹤0.01% |
41,679
+1,369
| +3% | +$24.6K |
|
2707
Rocky Brands
RCKY
$366M
| $759K | ﹤0.01% |
36,883
| – | – |
|
2708
Vishay Precision Group
VPG
$1.22B
| $759K | ﹤0.01% |
30,845
+4,757
| +18% | +$107K |
|
2709
CRA International
CRAI
$1.16B
| $752K | ﹤0.01% |
19,028
+58
| +0.3% | +$2.2K |
|
2710
Farmers National Banc Corp
FMNB
$939M
| $749K | ﹤0.01% |
63,123
+398
| +0.6% | +$4.6K |
|
2711
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
| $749K | ﹤0.01% |
11,172
-399
| -3% | -$25.3K |
|
2712
NVE Corp
NVEC
$562M
| $748K | ﹤0.01% |
12,083
+351
| +3% | +$20.1K |
|
2713
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $746K | ﹤0.01% |
24,766
+8,181
| +49% | +$244K |
|
2714
Ovid Therapeutics
OVID
$414M
| $744K | ﹤0.01% |
100,851
+82,273
| +443% | +$385K |
|
2715
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $743K | ﹤0.01% |
9,096
+1,665
| +22% | +$134K |
|
|
FARM
2716
DELISTED
Farmer Brothers
FARM
| $742K | ﹤0.01% |
101,076
+20,074
| +25% | +$161K |
|
2717
HCI Group
HCI
$2.23B
| $740K | ﹤0.01% |
16,016
| – | – |
|
2718
Westwood Holdings Group
WHG
$182M
| $733K | ﹤0.01% |
46,531
-3,878
| -8% | -$73.7K |
|
2719
Capital City Bank Group
CCBG
$888M
| $723K | ﹤0.01% |
34,500
+939
| +3% | +$18.4K |
|
|
CNCE
2720
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $717K | ﹤0.01% |
71,998
+4,873
| +7% | +$46.7K |
|
2721
Viemed Healthcare
VMD
$447M
| $712K | ﹤0.01% |
+74,090
| New | +$576K |
|
2722
AdaptHealth
AHCO
$1.47B
| $711K | ﹤0.01% |
+44,152
| New | +$738K |
|
|
RFP
2723
DELISTED
Resolute Forest Products Inc.
RFP
| $708K | ﹤0.01% |
335,195
-27,619
| -8% | -$52.3K |
|
|
ACRE
2724
Ares Commercial Real Estate
ACRE
$236M
| $707K | ﹤0.01% |
77,420
| – | – |
|
2725
Sterling Infrastructure
STRL
$18.3B
| $702K | ﹤0.01% |
66,954
+3,863
| +6% | +$35.7K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.